You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 7, 2025

CLINICAL TRIALS PROFILE FOR PHENAZINE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for PHENAZINE

Trial IDTitleStatusSponsorPhaseStart DateSummary
NCT04852510 ↗ Amelioration of Polycystic Ovary Syndrome Related Disorders by Supplementation of Thymoquinone and Metformin Completed Saudi German Hospital - Madinah Phase 2/Phase 3 2019-02-01 Objective: To investigate the potential benefit of adding Thymoquinone to Metformin in alleviating symptoms of polycystic ovarian syndrome. Methods: 207 overweight and obese PCOS Patients were divided into two groups. Patients in Group A, received Metformin 500 mg three times daily for 6 months. Patients in Group B, received a combination of Metformin 500 mg and Thymoquinone in the form of Black Cumin oil 500 mg capsules three times daily for 6 months. Follow up was done after 3 and 6 months from the beginning of the study for evaluation of menstrual cycle pattern, body mass index, Waist circumference, Hip circumference, and Waist / Hip ratio, Oral glucose tolerance test, Glycosylated Hemoglobin A1C, Superoxide dismutase activity and Malondialdehyde concentration.
NCT02473042 ↗ Intraoperative Acupoint Stimulation to Prevent Post-Operative Nausea and Vomiting (PONV) Active, not recruiting M.D. Anderson Cancer Center N/A 2016-02-01 The goal of this clinical research study is to learn if light electrical stimulation to the wrist area during surgery is feasible in women having breast surgery.
>Trial ID>Title>Status>Phase>Start Date>Summary
Showing 1 to 2 of 2 entries

Clinical Trial Conditions for PHENAZINE

Condition Name

1110-0.100.10.20.30.40.50.60.70.80.911.1Breast CancerPolycystic Ovary Syndrome (PCOS)Post-Operative Nausea and Vomiting[disabled in preview]
Condition Name for PHENAZINE
Intervention Trials
Breast Cancer 1
Polycystic Ovary Syndrome (PCOS) 1
Post-Operative Nausea and Vomiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

11110-0.100.10.20.30.40.50.60.70.80.911.1SyndromePolycystic Ovary SyndromeVomitingPostoperative Nausea and Vomiting[disabled in preview]
Condition MeSH for PHENAZINE
Intervention Trials
Syndrome 1
Polycystic Ovary Syndrome 1
Vomiting 1
Postoperative Nausea and Vomiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for PHENAZINE

Trials by Country

+
Trials by Country for PHENAZINE
Location Trials
Saudi Arabia 1
United States 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

+
Trials by US State for PHENAZINE
Location Trials
Texas 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for PHENAZINE

Clinical Trial Phase

50.0%50.0%0-0.100.10.20.30.40.50.60.70.80.911.1Phase 2/Phase 3N/A[disabled in preview]
Clinical Trial Phase for PHENAZINE
Clinical Trial Phase Trials
Phase 2/Phase 3 1
N/A 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

50.0%50.0%0-0.100.10.20.30.40.50.60.70.80.911.1Active, not recruitingCompleted[disabled in preview]
Clinical Trial Status for PHENAZINE
Clinical Trial Phase Trials
Active, not recruiting 1
Completed 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for PHENAZINE

Sponsor Name

trials000001111111M.D. Anderson Cancer CenterSaudi German Hospital - Madinah[disabled in preview]
Sponsor Name for PHENAZINE
Sponsor Trials
M.D. Anderson Cancer Center 1
Saudi German Hospital - Madinah 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

100.0%0-0.200.20.40.60.811.21.41.61.822.2Other[disabled in preview]
Sponsor Type for PHENAZINE
Sponsor Trials
Other 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Phenazine: Clinical Trials, Market Analysis, and Projections

Introduction to Phenazine

Phenazine, a heterocyclic organic compound, has garnered significant attention due to its diverse applications in medicine, technology, and agriculture. Its unique chemical structure and multifaceted properties make it an intriguing subject for research and development.

Clinical Trials and Research

Current State of Clinical Trials

While phenazine itself is not explicitly mentioned in ongoing clinical trials on ClinicalTrials.gov, its derivatives and related compounds are being studied for various medical applications. For instance, compounds with similar antimicrobial and anticancer properties are in various stages of clinical trials, particularly in the context of drug-resistant infections and cancer treatment[4].

Potential Applications in Clinical Settings

Phenazine's antimicrobial properties make it a potential candidate for developing novel antibiotics, which is crucial given the rising incidence of drug-resistant pathogens. Additionally, its role in photodynamic therapy offers a promising avenue for cancer treatment. These applications are driving research into new drug formulations and therapeutic solutions[2].

Market Analysis

Global Market Overview

The phenazine market is characterized by its diverse applications across various industries, including medicine, agriculture, and textiles. The global demand for phenazine is driven by the increasing trend towards sustainable farming practices, the need for innovative therapeutic solutions, and the growing preference for eco-friendly products.

Segment-Wise and Region-Wise Breakup

The global phenazine industry can be segmented based on application and region. In agriculture, phenazine-based biopesticides are gaining traction due to their effective pest and disease control with reduced environmental impact. In the healthcare sector, phenazine derivatives are being researched for their antimicrobial and anticancer properties. Region-wise, the market is expected to grow significantly in areas adopting sustainable practices and innovative technologies[2].

Price Analysis and Profit Margins

The report on phenazine manufacturing provides insights into the price analysis of feedstocks used in the manufacturing process, as well as industry profit margins. This includes detailed information on raw material requirements, utility costs, and other operational expenses that influence the overall profitability of phenazine production[2].

Market Projections

Growth Trends

The market for phenazine and its derivatives is poised for significant growth. In agriculture, the demand for phenazine-based biopesticides is driven by the shift towards sustainable farming practices. In healthcare, the rising incidence of drug-resistant infections and the quest for innovative therapeutic solutions are key drivers. Additionally, the textile industry's growing demand for eco-friendly and natural dyes further contributes to the market's upward trajectory[2].

Financial Projections

The financial projections for a phenazine manufacturing plant include detailed insights into project economics, such as capital investments, operating expenses, income and expenditure projections, and expected ROI and net present value (NPV). The report also covers financial analysis, including profit and loss accounts, to provide a comprehensive roadmap for investors and manufacturers[2].

Key Applications and Industries

Antimicrobial Agents

Phenazine's notable antimicrobial properties make it a potential candidate for developing novel antibiotics. This is particularly significant in the context of combating drug-resistant pathogens, a growing global health concern[2].

Electronic Materials and Biosensors

The redox activity of phenazine finds utility in various industrial processes, such as electron transfer mediators in microbial fuel cells and biosensors. This application highlights the compound's versatility beyond medical uses[2].

Photodynamic Therapy

Phenazine's unique chemical structure contributes to its effectiveness in photodynamic therapy, offering a promising avenue for cancer treatment. This application is being explored in clinical settings to develop new therapeutic strategies[2].

Agrochemicals

Derivatives of phenazine exhibit promising potential as agrochemicals, aiding in crop protection. This aligns with the increasing trend towards sustainable farming practices that minimize environmental impact[2].

Manufacturing Process and Requirements

Unit Operations and Raw Material Requirements

The manufacturing process of phenazine involves several unit operations, including synthesis, purification, and packaging. The report provides detailed information on raw material requirements, mass balance, and necessary quality assurance criteria and technical tests[2].

Machinery and Technology Requirements

Setting up a phenazine manufacturing plant requires specific machinery and technology. The report covers the necessary infrastructure, utility requirements, and manpower needs to ensure efficient and effective production[2].

Location Analysis

The location of a phenazine manufacturing plant is crucial and involves considerations such as land selection criteria, environmental impact, and expenditure. The report provides insights into these factors to help in the selection of an optimal location[2].

Challenges and Opportunities

Regulatory Frameworks

The development and approval of phenazine-based products must navigate regulatory frameworks. Adaptive licensing and global outcomes registries can streamline the approval process, especially for applications in drug-resistant tuberculosis and other critical health areas[4].

Market Competition

The market for phenazine and its derivatives is competitive, with several key players involved. Companies such as those in the perphenazine market (e.g., Teva, Sandoz, Endo, Mylan, ZHPHARMA) highlight the competitive landscape and the need for innovative strategies to stand out[3].

Key Takeaways

  • Diverse Applications: Phenazine has multifaceted applications in medicine, agriculture, and textiles.
  • Market Growth: The market is expected to grow significantly driven by sustainable practices and innovative technologies.
  • Clinical Trials: While phenazine itself is not in clinical trials, its derivatives are being studied for various medical applications.
  • Manufacturing Requirements: Setting up a phenazine manufacturing plant involves detailed planning of unit operations, raw materials, machinery, and location.
  • Regulatory Considerations: Navigating regulatory frameworks is crucial for the approval and commercialization of phenazine-based products.

FAQs

What are the primary applications of phenazine?

Phenazine has primary applications as antimicrobial agents, in photodynamic therapy, as agrochemicals, and in electronic materials and biosensors.

What drives the demand for phenazine in agriculture?

The demand for phenazine in agriculture is driven by the increasing trend towards sustainable farming practices and the need for effective pest and disease control with reduced environmental impact.

How does phenazine contribute to the healthcare sector?

Phenazine contributes to the healthcare sector through its antimicrobial and anticancer properties, making it a potential candidate for developing novel antibiotics and cancer treatments.

What are the key factors influencing the phenazine market?

The key factors influencing the phenazine market include the rising incidence of drug-resistant infections, the quest for innovative therapeutic solutions, and the growing preference for eco-friendly and sustainable products.

What is the projected growth rate of the phenazine market?

The phenazine market is expected to continue its upward trajectory, driven by various factors, although specific growth rates can vary depending on the segment and region.

Sources

  1. IMARC Group: "Phenazine Manufacturing Plant Project Report 2024: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue."
  2. IMARC Group: "Phenazine Manufacturing Plant Report 2024: Setup Cost."
  3. Business Research Insights: "Perphenazine Market Size - [2024 To 2032] Growth Report."
  4. Oxford Academic: "Sustainable Tuberculosis Drug Development."

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.